Sector ratings Laboratorios Farmaceuticos Rovi, S.A.

Stocks

Real-time Estimate Tradegate 12:48:35 26/08/26 am AEST			5-day change	1st Jan Change
60.48 ^EUR	+1.04%		+4.40%	-4.65%

23/07	Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026
23/07	Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026	CI

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
LABORATORIOS FARMACEUTICOS ROVI, S.A.	3.57B		BBB
ELI LILLY AND COMPANY	1,111B		A
JOHNSON & JOHNSON	658B	-	BBB	-	-
ABBVIE INC.	467B		AA		-
ROCHE HOLDING AG	369B		AA
NOVARTIS AG	301B		AAA
ASTRAZENECA PLC	256B		A
AMGEN INC.	240B		A
NOVO NORDISK A/S	207B		A
GILEAD SCIENCES, INC.	182B		AA
PFIZER INC.	159B		A
VERTEX PHARMACEUTICALS INCORPORATED	139B		AA
BRISTOL-MYERS SQUIBB COMPANY	137B		A
SANOFI	109B		AA
GSK PLC	103B		AA
CHUGAI PHARMACEUTICAL CO., LTD.	72.26B		AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	58.19B		AA
BAYER AG	55.58B		AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	45.78B		AA
HALEON PLC	44.44B		AA
Average	235.96B		AA
Weighted average by Cap.			AA